A Peculiar Case of Recurrent Coronary Artery Thrombosis

Samuel Nwaobi1, Zachary Wood2, Aarushi Kalra3

  • 1Family Medicine, Piedmont Columbus Regional Midtown, Columbus, USA.

Cureus
|October 28, 2022
PubMed

Insights

This case report details recurrent coronary artery thrombosis in a patient with Factor V Leiden deficiency despite dual antiplatelet therapy and a drug-eluting stent. It underscores the need for research into genetic risk factors and anticoagulation efficacy.

Area of Science:

  • Cardiology
  • Genetics
  • Thrombosis

Background:

  • Coronary artery thrombosis is a significant clinical concern, influenced by numerous risk factors including atherosclerosis.
  • Understanding plaque formation and blockage is crucial for patient diagnosis and management.

Observation:

  • A 54-year-old female presented with acute chest pain and ST-elevation myocardial infarction (STEMI) despite dual antiplatelet therapy.
  • Her history included Factor V Leiden deficiency, hyperhomocysteinemia, and recurrent deep vein thrombosis (DVT).
  • She experienced repeat thrombosis in a stented right coronary artery (RCA) within nine months, despite medication compliance.

Findings:

  • The patient was diagnosed with 100% thrombosis in the distal RCA, nine months after initial stenting.
  • A new drug-eluting stent (DES) was implanted, and anticoagulation with prasugrel and apixaban was initiated.
  • This case highlights rare same-vessel restenosis post-DES placement in a patient with a hypercoagulable state.

Implications:

  • This case emphasizes the need for further research into the prevalence of genetic risk factors in coronary artery thrombosis.
  • Investigating the efficacy of various anticoagulation therapies in patients with Factor V Leiden thrombophilia is warranted.
  • Further studies are needed to understand repeat thrombosis in stented arteries, especially in patients with inherited thrombophilia.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
23
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
35
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
3.5K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
23
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46